A blog about what is new (and old) in the world of active implantable medical devices 

Facebook Twitter Gplus Flickr LinkedIn YouTube RSS
magnify
Home AIMD Companies EnteroMedics Leptos Biomedical’s Splanchnic Nerve Stimulation For Treatment Of Obesity (2002-2010)
formats

Leptos Biomedical’s Splanchnic Nerve Stimulation For Treatment Of Obesity (2002-2010)

Leptos Biomedical, Inc. Splanchnic nerve stimulation for treatment of obesityLeptos Biomedical was founded in Fridley, MN in 2002 by Dr. John D. Dobak.   Leptos intended to develop an implantable device to stimulate the greater splanchnic nerve, that was hoped would  result in reduced food intake and increased energy expenditure.

In February 2010 Leptos announced its closure.  Reasons were not provided, but it has been suggested that the decision was prompted by the 2009 announcement by competitor EnteroMedics’ that it had failed to meet the primary goals of its pivotal study. EnteroMedics’ Maestro device didn’t perform any better than a sham device.  EnteroMedics is now conducting a new study with the device.

Click here for Leptos Biomedical’s patents.

 

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Leptos Biomedical’s Splanchnic Nerve Stimulation For Treatment Of Obesity (2002-2010)  comments